Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1977-11-15
1980-02-19
Rosen, Sam
Drug, bio-affecting and body treating compositions
Lymphokine
424 86, 424 87, A61K 3942, A61K 3940, A61K 3900
Patent
active
041894707
ABSTRACT:
A process for the removal of a specific antibody from the lymph fluid free of lymph cells is disclosed. The lymph is taken from a subject (e.g., human or animal) by means of a thoracic duct fistula by raising the pressure of the central venous system in order that the pressure is above the atmospheric pressure of the thoracic duct. Lymph is separated into cells and lymph fluid containing antibodies. Cells are returned to the subject intravenously. Lymph fluid is mixed with substrate particles attached with specific antigens. An antibody-antigen-substrate particle complex is formed and removed. Subsequently, specific antibody can be split from the specific antigens attached to a substrate particle. The antigen-attached substrate particles can then be re-used. Specific antibody can be introduced into another subject or used for other purposes in biology, in chemistry, and in veterinary and clinical medicine.
REFERENCES:
patent: 3639559 (1972-02-01), Tax
patent: 3652761 (1972-03-01), Weetall
Bio-Response, Inc.
Rosen Sam
LandOfFree
Method for the continuous removal of a specific antibody from th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the continuous removal of a specific antibody from th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the continuous removal of a specific antibody from th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-653282